These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 25162361

  • 1. Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children.
    O'Meara M, Cicalese MP, Bordugo A, Ambrosi A, Hadzic N, Mieli-Vergani G.
    J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):48-53. PubMed ID: 25162361
    [Abstract] [Full Text] [Related]

  • 2. Octreotide for recurrent intestinal variceal bleeding in patients without portal hypertension.
    Dray X, Vahedi K, Odinot JM, Marteau P.
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):836-9. PubMed ID: 19381096
    [Abstract] [Full Text] [Related]

  • 3. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.
    Nardone G, Compare D, Scarpignato C, Rocco A.
    Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688
    [Abstract] [Full Text] [Related]

  • 4. Long-acting Release Octreotide for Pediatric Upper Gastrointestinal Bleeding.
    Malla I, López S, Busquet L, Lipsich J, Sierre S, Cervio G, Cuarterolo M.
    Rev Chil Pediatr; 2020 Apr; 91(2):251-254. PubMed ID: 32730545
    [Abstract] [Full Text] [Related]

  • 5. Randomised clinical trial: the safety and efficacy of long-acting octreotide in patients with portal hypertension.
    Chandok N, Kamath PS, Blei A, Bosch J, Carey W, Grace N, Kowdley KV, Benner K, Groszmann RJ.
    Aliment Pharmacol Ther; 2012 Apr; 35(8):904-12. PubMed ID: 22380529
    [Abstract] [Full Text] [Related]

  • 6. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L, Giostra E, Frossard JL, Morard I, Mentha G, Hadengue A.
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [Abstract] [Full Text] [Related]

  • 7. Optimizing medical therapy of acromegaly: beneficial effects of cabergoline in patients uncontrolled with long-acting release octreotide.
    Jallad RS, Bronstein MD.
    Neuroendocrinology; 2009 Jul; 90(1):82-92. PubMed ID: 19439914
    [Abstract] [Full Text] [Related]

  • 8. Investigation into the efficacy and safety of octreotide LAR in Japanese patients with acromegaly: Shizuoka study.
    Oki Y, Inoue T, Imura M, Tanaka T, Genma R, Iwabuchi M, Hataya Y, Matsuzawa Y, Iino K, Nishizawa S, Nakamura H.
    Endocr J; 2009 Jul; 56(9):1095-101. PubMed ID: 19755754
    [Abstract] [Full Text] [Related]

  • 9. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia.
    Scaglione G, Pietrini L, Russo F, Franco MR, Sorrentini I.
    Aliment Pharmacol Ther; 2007 Sep 15; 26(6):935-42. PubMed ID: 17767478
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
    Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G.
    J Clin Endocrinol Metab; 2001 Jun 15; 86(6):2779-86. PubMed ID: 11397887
    [Abstract] [Full Text] [Related]

  • 11. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS, Musolino NR, Salgado LR, Bronstein MD.
    Clin Endocrinol (Oxf); 2005 Aug 15; 63(2):168-75. PubMed ID: 16060910
    [Abstract] [Full Text] [Related]

  • 12. Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
    Turner HE, Thornton-Jones VA, Wass JA.
    Clin Endocrinol (Oxf); 2004 Aug 15; 61(2):224-31. PubMed ID: 15272918
    [Abstract] [Full Text] [Related]

  • 13. Octreotide therapy for control of acute gastrointestinal bleeding in children.
    Eroglu Y, Emerick KM, Whitingon PF, Alonso EM.
    J Pediatr Gastroenterol Nutr; 2004 Jan 15; 38(1):41-7. PubMed ID: 14676593
    [Abstract] [Full Text] [Related]

  • 14. A pilot study of Octreotide LAR vs. octreotide tid for pain and quality of life in chronic pancreatitis.
    Lieb JG, Shuster JJ, Theriaque D, Curington C, Cintrón M, Toskes PP.
    JOP; 2009 Sep 04; 10(5):518-22. PubMed ID: 19734628
    [Abstract] [Full Text] [Related]

  • 15. Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device.
    Juricek C, Imamura T, Nguyen A, Chung B, Rodgers D, Sarswat N, Kim G, Raikhelkar J, Ota T, Song T, Burkhoff D, Sayer G, Jeevanandam V, Uriel N.
    J Card Fail; 2018 Apr 04; 24(4):249-254. PubMed ID: 29427603
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
    Penning C, Vecht J, Masclee AA.
    Aliment Pharmacol Ther; 2005 Nov 15; 22(10):963-9. PubMed ID: 16268971
    [Abstract] [Full Text] [Related]

  • 17. Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.
    Matulonis UA, Seiden MV, Roche M, Krasner C, Fuller AF, Atkinson T, Kornblith A, Penson R.
    J Pain Symptom Manage; 2005 Dec 15; 30(6):563-9. PubMed ID: 16376743
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of long-acting somatostatin analogs in recurrent variceal bleeding in a patient with pre-hepatic portal vein thrombosis.
    Alempijević T, Balović A, Pavlović-Marković A, Tarabar D, Krstić M, Miljić P, Bjelović M.
    Vojnosanit Pregl; 2015 Mar 15; 72(3):283-6. PubMed ID: 25958482
    [Abstract] [Full Text] [Related]

  • 19. Octreotide long-active release in the treatment of gastrointestinal bleeding due to vascular malformations: Cost-effectiveness study.
    Klímová K, Padilla-Suárez C, Giménez-Manzorro Á, Pajares-Díaz JA, Clemente-Ricote G, Hernando-Alonso A.
    Rev Esp Enferm Dig; 2015 Feb 15; 107(2):79-88. PubMed ID: 25659389
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
    Arts J, Caenepeel P, Bisschops R, Dewulf D, Holvoet L, Piessevaux H, Bourgeois S, Sifrim D, Janssens J, Tack J.
    Clin Gastroenterol Hepatol; 2009 Apr 15; 7(4):432-7. PubMed ID: 19264574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.